| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/21/2002 | WO2001053338A3 Cbp86, a sperm specific protein |
| 02/21/2002 | WO2001046698A3 Tethered ligands and methods of use |
| 02/21/2002 | WO2001046397A3 Human kinases |
| 02/21/2002 | WO2001044511A3 Methods and compositions for detection of mycobacterium avium complex species |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001031566A3 Apparatus and methods for verifying the location of areas of interest within a sample in an imaging system |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001030967A3 Fluorescent cobalamins and uses thereof |
| 02/21/2002 | WO2001027624A3 Compositions and methods for detecting protein modification and enzymatic activity |
| 02/21/2002 | WO2001023605A3 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
| 02/21/2002 | WO2001023586A3 Transacylases of the paclitaxel biosynthetic pathway |
| 02/21/2002 | WO2001018524A3 Methods for improving signal detection from an array |
| 02/21/2002 | WO2000075662A9 Cell-signaling assays |
| 02/21/2002 | WO2000073797A9 Homogeneous tests for sequentially determining lipoprotein fractions |
| 02/21/2002 | WO2000067737A9 USE OF HMGCoA REDUCTASE INHIBITORS IN THE PREVENTION OF DISEASES WHOSE PATHOGENESIS IS DEPENDENT ON NEOVASCULARIZATION |
| 02/21/2002 | WO2000065095A3 Methods and compositions for performing array based hybridization assays |
| 02/21/2002 | WO2000062036A9 Amplification and separation of nucleic acid sequences using strand displacement amplification and bioelectronic microchip technology |
| 02/21/2002 | WO2000061819A3 Methods of detection and modulation of age-related mutations |
| 02/21/2002 | WO2000061809A3 Methods and nucleic acid vectors for rapid and parallel assay development, for characterization of biological response modifiers |
| 02/21/2002 | WO2000060125A3 High resolution dna detection methods and devices |
| 02/21/2002 | US20020023281 Expressed sequences of arabidopsis thaliana |
| 02/21/2002 | US20020023280 Expressed sequences of arabidopsis thaliana |
| 02/21/2002 | US20020022933 Chemical structure identification |
| 02/21/2002 | US20020022721 Methods of array synthesis |
| 02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
| 02/21/2002 | US20020022716 Detecting modulator of protein activity; mix modulator and target protein complex, incubate with enzyme and substrate, measure enzyme activity, adjustment in activity indicates modulator |
| 02/21/2002 | US20020022599 Methods of modulating drug clearance mechanisms by altering SXR activity |
| 02/21/2002 | US20020022276 Individually addressable micro-electromagnetic unit array chips |
| 02/21/2002 | US20020022275 Cloning and copying on surfaces |
| 02/21/2002 | US20020022268 Culturing primate progenitor tissues; obtain tissues, harvest nutrients from culture, monitor tissue propagation |
| 02/21/2002 | US20020022259 Cardiac-cell specific enhancer elements and uses thereof |
| 02/21/2002 | US20020022254 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | US20020022245 Method of identifying compounds suitable for treatment and/or prophylaxis of obesity |
| 02/21/2002 | US20020022243 Profiling of protease specificity using combinatorial fluorogenic substrate libraries |
| 02/21/2002 | US20020022242 Detection of preferential nervous system disorder; obtain sample of body fluid, detect preferential enzyme with adjusted glycosylation pattern |
| 02/21/2002 | US20020022238 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
| 02/21/2002 | US20020022233 Screening a library of small organic compound to identify those having affinity for a particular site on a biomolecular target, by forming a covalent bond with a chemically reactive group at that site |
| 02/21/2002 | US20020022232 Computing fittings between sample nucleic acid and control; generate indicators, compute transformational adjustments, determine possible conformational patterns |
| 02/21/2002 | US20020022231 Method for identifying modulators of DNA structure-specific binding proteins by high-throughput screening |
| 02/21/2002 | US20020022230 Compositions and methods for directly and rapidly analyzing the biochemical components of microorganisms |
| 02/21/2002 | US20020022229 Detecting genetic disorder; obtain sample, detect bone morphogenic protein mutation, the presence of mutation indicates genetic disorder |
| 02/21/2002 | US20020022228 Evaluating nucleotide sequence maintenance; provide nucleotide sequences, incubate with maintenance enzymes, monitor nucleotide sequence for enzymatic removal of preferential nucleotide sequences |
| 02/21/2002 | US20020022227 Morphatides: novel shape and structure libraries |
| 02/21/2002 | US20020022226 Method and device for detecting hybridization reaction |
| 02/21/2002 | US20020022225 Method for detecting the presence of at least one single allele of a deletion mutant |
| 02/21/2002 | US20020022224 Directly from double stranded PCR products by amplification using two oligonucleotide primers, one of which is tagged to form a tagged amplification product and a complementary non-tagged product, separation |
| 02/21/2002 | US20020022223 Screening for target nucleotide sequences; join oligonucleotide probes to electronic leads, incubate with target nucleotide sequences, hybridize, apply eletrical current, leads carring current indicates bound target |
| 02/21/2002 | US20020022222 Method of preparing a standard diagnostic gene transcript pattern |
| 02/21/2002 | US20020022221 Organelle targeting protein; for use in treatment of viral disease |
| 02/21/2002 | US20020022218 Methods for the identification of compounds useful for the treatment of disease states medicated by prostaglandin D2 |
| 02/21/2002 | US20020022217 High density streptavidin supports |
| 02/21/2002 | US20020022053 Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis, and pharmaceutical compositions and kit related thereto |
| 02/21/2002 | US20020022033 Diagnosis of Aids |
| 02/21/2002 | US20020022026 Osteoporosis |
| 02/21/2002 | US20020021299 Method for displaying results of hybridization experiment |
| 02/21/2002 | US20020020632 Membrane based electrochemical test device and related methods |
| 02/21/2002 | DE10038733A1 Verfahren zur Altersbestimmung von Individuen Method for determining the age of individuals |
| 02/21/2002 | DE10038382A1 Zweifarbiges fluorimetrisches Proteaseassay Two-toned fluorometric protease assay |
| 02/21/2002 | DE10037769A1 Diagnose von mit CD24 assoziierten Krankheiten Diagnosis of diseases associated with CD24 |
| 02/21/2002 | DE10025384A1 Quantitative Messung von Molekülmengen im komplexen Gemischen Quantitative measurement of molecular quantities in complex mixtures |
| 02/21/2002 | DE10025379A1 Bestimmung von NAALADase-Inhibitoren Determination of NAALADase inhibitors |
| 02/21/2002 | CA2419985A1 Modulating multiple lineage kinase proteins |
| 02/21/2002 | CA2419529A1 Diagnosis and treatment of tumor-suppressor associated disorders |
| 02/21/2002 | CA2419481A1 Bioluminescent methods for direct visual detection of environmental compounds |
| 02/21/2002 | CA2419159A1 Ultra-sensitive detection systems |
| 02/21/2002 | CA2419126A1 Basecalling system and protocol |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | CA2418861A1 Method and device for characterising and/or for detecting a bonding complex |
| 02/21/2002 | CA2418320A1 The anti-neoplastic agent et-743 inhibits trans activation by sxr |
| 02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2418087A1 Use of microbial dna sequences for the identification of human diseases |
| 02/21/2002 | CA2417986A1 Single-labeled oligonucleotide probes |
| 02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
| 02/21/2002 | CA2417088A1 Methods and molecules useful for identifying molecules that bind lfa-1 and for determining receptor occupancy |
| 02/20/2002 | EP1180686A1 Remedies for kidney diseases and method for screening the same |
| 02/20/2002 | EP1180677A2 A method and a system for determination of particles in a liquid sample |
| 02/20/2002 | EP1180676A2 A method and a system for determination of particles in a liquid sample |
| 02/20/2002 | EP1180675A2 A method and a system for determination of particles in a liquid sample |
| 02/20/2002 | EP1180549A1 Method of measuring polymorphism |
| 02/20/2002 | EP1180548A2 Array based methods for synthesizing nucleic acid mixtures |
| 02/20/2002 | EP1180547A2 Method for producing DNA |
| 02/20/2002 | EP1180546A1 Human cell line showing stable expression of cytochromes p450 |
| 02/20/2002 | EP1180244A2 High troughput assay systems and methods |
| 02/20/2002 | EP1180239A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 02/20/2002 | EP1180238A1 Device and method for isolating electrically charged molecules |
| 02/20/2002 | EP1180170A1 Polynucleotide arrays and methods of making and using the same |
| 02/20/2002 | EP1180169A1 Methods of detecting polynucleotide kinase and its use as a label |
| 02/20/2002 | EP1180168A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS |
| 02/20/2002 | EP1180167A1 In vivo selection method for determining inhibitory rna molecules |
| 02/20/2002 | EP1180166A1 Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject |
| 02/20/2002 | EP1180165A2 A nematode drug screen for modulators of mammalian disorders |
| 02/20/2002 | EP1180163A1 Monitoring gene expression |
| 02/20/2002 | EP1180162A2 An apparatus for the analysis of the electrophysiology of neuronal cells and its use in high-throughput functional genomics |
| 02/20/2002 | EP1180160A1 Antibiotic-based gene regulation system |
| 02/20/2002 | EP1180152A1 Recombinant bacterial phytases and uses thereof |
| 02/20/2002 | EP1180151A2 Protein kinases |
| 02/20/2002 | EP1180147A1 Secreted alpha-helical protein-31 |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180142A2 Methods and compositions for measuring ion channel conductance |